NNNN CIK: 1982708

Anbio Biotechnology

  • Germany
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
2.54
FY22:
12.6
FY23:
3.36
FY24:
5.89
FY25:
7.54
(positive)
Change from FY21 to FY25
millions USD
FY21:
2.46
FY22:
10.2
FY23:
1.96
FY24:
2.00
FY25:
5.77
(positive)
Change from FY21 to FY25
millions USD
FY21:
2.54
FY22:
10.3
FY23:
1.85
FY24:
1.97
FY25:
5.27
(positive)
Change from FY21 to FY25
millions USD
FY21:
2.54
FY22:
10.0
FY23:
2.25
FY24:
2.37
FY25:
6.40
(positive)
Change from FY21 to FY25
millions USD
FY21:
2.54
FY22:
10.0
FY23:
2.25
FY24:
2.37
FY25:
6.40

All amounts in millions USD FY21: figures supplemented from Twelve Data because the SEC filings do not reach back this far. Data sources:SEC EDGARTwelve Data